Beyond hazard ratios, investigators used restricted mean survival time (RMST) analysis to compare survival gains across trialed ICI combinations for mRCC.

Testosterone replacement therapy (TRT) is linked to a significantly lower risk of major CV events in men with secondary hypogonadism.

Researchers present consensus statement for core competencies to guide education for medical students on medical cannabis use.

Investigators compared PSA90 response between new users of apalutamide vs abiraterone for mCSPC using a large US cohort.

Persistent hematuria in patients diagnosed with lupus nephritis independently predicts adverse outcomes. Patients who have hematuria at lupus nephritis (LN) diagnosis that does not improve but rather ...

Credit: Getty Images Magnesium helps regulate other electrolytes, particularly calcium and potassium, reducing the risk of arrhythmias common in CKD patients. Assessing and managing magnesium in ...

AKI or acute kidney injury is a complex clinical disorder frequently seen in hospitalized critically ill patients. 1 It is defined as a functional or structural kidney abnormality in which a patient ...

Men overestimate the risks for clinically significant prostate cancer based on prostate MRI PI-RADS findings, regardless of the context in which those risks are presented, suggesting that clinicians ...

The addition of RARP to ADT significantly increased the rate of achieving radical level PSA levels (74.7% vs 38.3%; P <.001) and a shorter time to PSA nadir (2 vs 6 months; P <.001) compared with ADT ...

GLP-1 RA therapy linked to significantly lower risk for epilepsy compared with DPP4-i use among adults with T2DM.

Credit: Getty Images A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the best to prescribe upfront—and to which patients. The ...

Old man taking a pill New studies demonstrate possible protective effect of SGLT2 inhibitors and GLP-1 agonists. Use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) or glucagon-like peptide-1 ...